News
U.S. Market Leads with 74% Share in 2023 Valued at USD 2.71 Billion, Driven by Biotech Innovation, Favorable FDA Approvals, and Rising Chronic Disease Incidence.Austin, July 18, 2025 (GLOBE NEWSWIRE) ...
The program is the latest example of pharmaceutical companies bypassing traditional drug distribution channels for people who ...
Zacks Investment Research on MSN23h
Eli Lilly vs. Merck: Which Drug Giant Appears Better Poised Today?Both Eli Lilly LLY and Merck MRK are major players in the U.S. pharmaceutical industry, developing and commercializing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback